| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 0 | 2 | 3 | 34 | 48 | 34 | 54 | 61 | 53 | 51 | 44 | 37 |
| Expenses | 5 | 14 | 11 | 41 | 58 | 52 | 71 | 94 | 68 | 59 | 58 | 51 |
| EBITDA | -5 | -11 | -8 | -7 | -10 | -18 | -17 | -33 | -15 | -8 | -14 | -14 |
| Operating Profit % | 0 % | -962 % | -246 % | -22 % | -21 % | -56 % | -33 % | -57 % | -30 % | -17 % | -35 % | -47 % |
| Depreciation | 2 | 5 | 4 | 4 | 4 | 5 | 5 | 6 | 7 | 7 | 7 | 7 |
| Interest | 4 | 1 | 4 | 5 | 6 | 6 | 6 | 5 | 3 | 5 | 6 | 6 |
| Profit Before Tax | -8 | -16 | -16 | -18 | -20 | -29 | -28 | -45 | -25 | -20 | -27 | -27 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -8 | -16 | -16 | -18 | -20 | -29 | -28 | -45 | -25 | -20 | -27 | -27 |
| EPS in ₹ | -8.24 | -12.49 | -11.68 | -12.97 | -12.83 | -17.90 | -14.37 | -20.81 | -11.30 | -9.15 | -12.49 | -12.60 |
Krebs Biochemicals & Industries
Krebs Biochemicals & Industries
79.84
+1.38
(1.76%)
Market Cap
169.20 Cr
EPS
-12.49
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
129.07
52 Week Low
66.12
PB Ratio
-1.17
Debt to Equity
0.00
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Company News
View All News
Krebs Biochemicals and Industries Limited published its unaudited financial results for the quarter ended June 30, 2025. The company reported total income from operations of Rs 549.26 lakhs, down from Rs 643.85 lakhs in the previous quarter and Rs 1,292.25 lakhs in the same quarter last year. The company posted a net loss of Rs 532.43 lakhs for the quarter, compared to a loss of Rs 825.31 lakhs in the previous quarter and Rs 517.11 lakhs in the corresponding quarter of the previous year. Total comprehensive income showed a loss of Rs 532.43 lakhs. The company's equity share capital remained unchanged at Rs 2,156.06 lakhs. Basic and diluted earnings per share were negative at Rs 2.47 per share of Rs 10 each. The board approved these results on August 7, 2025, and they were published in newspapers on August 8, 2025.
Krebs Biochemicals & Industries Ltd approved its unaudited financial results for the first quarter ended June 30, 2025. The company appointed Manish Kumar Jain as Additional Director and Managing Director & CEO effective August 7, 2025, for a five-year term until August 6, 2028, subject to shareholder approval. Jain is a Chartered Accountant with over 25 years of experience in Strategic Planning, Finance and Business Development. Simultaneously, Jitendra Shah resigned from his position as Managing Director & CEO effective August 7, 2025, citing personal reasons. The Board reconstituted its Audit Committee and Stakeholder Relationship Committee effective August 8, 2025, with both committees now including the new Managing Director alongside existing independent directors.
Krebs Biochemicals & Industries Ltd announced its unaudited financial results for the first quarter ended June 30, 2025, alongside significant leadership changes. The company appointed Manish Kumar Jain as Additional Director and Managing Director & CEO effective August 7, 2025, for a five-year term until August 6, 2028, subject to shareholder approval. Jain is a Chartered Accountant with over 25 years of experience in Strategic Planning, Finance and Business Development. Simultaneously, Jitendra Shah resigned from his position as Managing Director & CEO effective August 7, 2025, citing personal reasons. The Board also reconstituted its committees effective August 8, 2025, with the Audit Committee chaired by P M Kathariya and the Stakeholder Relationship Committee chaired by Sumanth Karlapudi, both including the new Managing Director among their members.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,620.20 | #1 3,86,412.90 | 33.89 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 49.41 | |
6,051.50 | 1,61,922.60 | 69.65 | 9,712.00 | 18.67 | 2,191 | 26.74 | 46.47 | |
1,559.60 | 1,25,921.60 | 23.36 | 28,409.50 | 7.12 | 5,291 | 9.88 | 51.03 | |
3,548.30 | 1,19,657.40 | 59.39 | 11,539.40 | 6.99 | 1,911 | 19.91 | 42.91 | |
1,311.40 | 1,09,362.20 | #1 19.26 | 33,741.20 | 16.73 | 5,725 | 1.26 | 60.11 | |
2,570.20 | 1,06,063.00 | 56.09 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 53.12 | |
1,033.80 | 1,04,094.90 | 22.34 | 23,511.00 | 18.55 | 4,615 | 2.60 | 62.88 | |
2,031.20 | 93,704.80 | 25.08 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 68.18 | |
5,472.50 | 65,796.60 | 28.79 | 13,458.30 | 3.70 | 2,216 | 21.39 | 70.33 | |
30,970.00 | 65,724.10 | 45.28 | 6,684.70 | 9.64 | 1,414 | 11.55 | 39.16 |
Forecast
Actual
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-434.32 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 108 | 116 | 122 | 126 | 142 | 134 | 159 | 190 | 175 | 178 | 169 |
| Fixed Assets | 58 | 93 | 102 | 101 | 101 | 105 | 118 | 139 | 147 | 150 | 146 |
| Current Assets | 15 | 9 | 13 | 17 | 31 | 19 | 21 | 36 | 16 | 17 | 10 |
| Capital Work in Progress | 0 | 11 | 4 | 4 | 4 | 4 | 12 | 8 | 4 | 2 | 3 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 50 | 13 | 16 | 21 | 38 | 24 | 29 | 43 | 24 | 26 | 20 |
| Total Liabilities | 108 | 116 | 122 | 126 | 142 | 134 | 159 | 190 | 175 | 178 | 169 |
| Current Liabilities | 29 | 30 | 32 | 42 | 55 | 43 | 48 | 78 | 49 | 62 | 104 |
| Non Current Liabilities | 61 | 74 | 89 | 101 | 102 | 116 | 154 | 187 | 225 | 236 | 212 |
| Total Equity | 18 | 13 | 2 | -18 | -14 | -25 | -43 | -75 | -100 | -119 | -146 |
| Reserve & Surplus | -14 | -4 | -12 | -32 | -31 | -43 | -67 | -97 | -121 | -141 | -168 |
| Share Capital | 10 | 13 | 14 | 14 | 17 | 18 | 20 | 22 | 22 | 22 | 22 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 6 | -6 | -0 | 0 | 17 | -17 | 1 | -1 | 0 | 0 | 0 |
| Investing Activities | -3 | -4 | -5 | -3 | -4 | -10 | -23 | -23 | -13 | -8 | -5 |
| Operating Activities | -45 | -15 | -11 | -6 | 4 | -36 | -15 | -17 | -25 | 2 | -8 |
| Financing Activities | 54 | 13 | 16 | 9 | 17 | 29 | 38 | 40 | 37 | 6 | 13 |
Share Holding
| % Holding | Mar 2021 | Apr 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 70.05 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.00 % | 0.01 % | 0.50 % | 0.50 % | 0.50 % | 0.50 % | 0.50 % | 0.50 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 19.03 % | 17.32 % | 18.26 % | 19.34 % | 18.96 % | 19.24 % | 19.26 % | 18.77 % | 18.67 % | 18.57 % | 18.54 % | 18.80 % | 19.00 % | 20.11 % | 19.97 % | 19.80 % | 20.02 % | 20.42 % | 19.73 % |
| Others | 10.92 % | 9.94 % | 9.00 % | 7.91 % | 8.30 % | 8.01 % | 8.00 % | 8.48 % | 8.59 % | 8.68 % | 8.71 % | 8.45 % | 8.25 % | 6.65 % | 6.79 % | 6.96 % | 6.74 % | 6.34 % | 7.03 % |
| No of Share Holders | 0 | 6,400 | 6,400 | 7,096 | 8,571 | 8,166 | 9,531 | 9,533 | 9,650 | 9,294 | 9,393 | 9,030 | 8,990 | 8,909 | 8,848 | 9,425 | 9,091 | 8,798 | 9,118 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 26 Sept 2025 |  Annual General Meeting | NA | 26 Sept 2025 | 73.50 | 78.75 |
| 01 Feb 2019 |  Rights | 21:100 | 31 Jan 2019 | 110.30 | 97.70 |
| 27 Sept 2024 | Annual General Meeting | NA | 27 Sept 2024 | 82.67 | 82.25 |
| 11 Nov 2024 |  Quarterly Result Announcement | NA | 11 Nov 2024 | 77.10 | 92.51 |
| 04 Feb 2025 | Quarterly Result Announcement | NA | 04 Feb 2025 | 90.26 | 97.00 |
| 20 May 2025 | Quarterly Result Announcement | NA | 20 May 2025 | 73.00 | 77.72 |
| 07 Aug 2025 | Quarterly Result Announcement | NA | 07 Aug 2025 | 82.49 | 79.86 |
Announcements
Report On Re-Lodgement Of Transfer Requests Of Physical Shares
6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Newspaper PublicationAug 29, 2025
Aug 29, 2025Notice Of 33Rd Annual General Meeting Of The CompanyAug 28, 2025
Aug 28, 2025Reg. 34 (1) Annual Report.Aug 28, 2025
Aug 28, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2025
Aug 08, 2025Board Comments On Fine Levied By ExchangesAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 07, 2025
Aug 07, 2025ResultAug 07, 2025
Aug 07, 2025Board Meeting Outcome for Outcome Of Board MeetingAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 25, 2025
Jul 25, 2025Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 7Th August 2025Jul 22, 2025
Jul 22, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 03, 2025
Jul 03, 2025Closure of Trading WindowJun 23, 2025
Jun 23, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
May 28, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
May 21, 2025Result For The Year Ended 31.03.2025May 20, 2025
May 20, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 20Th May 2025May 20, 2025
May 20, 2025Board Meeting Intimation for To Consider And Approved Audited Financial Results For 4Th Quarter And Year Ended 31.03.2025May 07, 2025
May 07, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 02, 2025
Apr 02, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 31, 2025
Mar 31, 2025Announcement under Regulation 30 (LODR)-CessationMar 24, 2025
Mar 24, 2025Closure of Trading WindowMar 18, 2025
Mar 18, 2025Announcement under Regulation 30 (LODR)-CessationMar 10, 2025
Mar 10, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 26, 2025
Feb 26, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 24, 2025
Feb 24, 2025Announcement under Regulation 30 (LODR)-CessationFeb 11, 2025
Feb 11, 2025Order Received From Andhra Pradesh Pollution Control BoardFeb 10, 2025
Feb 10, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderFeb 10, 2025
Feb 10, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 05, 2025
Feb 05, 2025Reconstitution Of Various Committees Of The Board Of CompanyFeb 04, 2025
Feb 04, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 04, 2025
Feb 04, 2025Integrated Filing (Financial)Feb 04, 2025
Feb 04, 2025Financial Result For The Quarter Ended 31.12.2024Feb 04, 2025
Feb 04, 2025Board Meeting Outcome for Outcome Of Board MeetingFeb 04, 2025
Feb 04, 2025Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 15, 2025
Jan 15, 2025Integrated Filing (Governance)Jan 13, 2025
Jan 13, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 02, 2025
Jan 02, 2025Announcement under Regulation 30 (LODR)-CessationDec 31, 2024
Dec 31, 2024Reply To Clarification Sought On Price MovementNov 28, 2024
Nov 28, 2024Clarification sought from Krebs Biochemicals & Industries LtdNov 28, 2024
Nov 28, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 12, 2024
Nov 12, 2024Financial Result For The Quarter And Half Year Ended 30.09.2024Nov 11, 2024
Nov 11, 2024Board Meeting Outcome for Outcome Of Board MeetingNov 11, 2024
Nov 11, 2024Board Meeting Intimation for Intimation Of Board MeetingOct 28, 2024
Oct 28, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 04, 2024
Oct 04, 2024Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 28, 2024
Sep 28, 2024Shareholder Meeting / Postal Ballot-Outcome of AGMSep 27, 2024
Sep 27, 2024Closure of Trading WindowSep 23, 2024
Sep 23, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2024
Sep 04, 2024Notice Of 32Nd Annual General Meeting Of The CompanySep 02, 2024
Sep 02, 2024Technical Indicators
RSI(14)
Neutral 61.06
ATR(14)
Volatile 3.86
STOCH(9,6)
Neutral 74.04
STOCH RSI(14)
Overbought 88.16
MACD(12,26)
Bullish 0.95
ADX(14)
Weak Trend 23.22
UO(9)
Bearish 49.95
ROC(12)
Uptrend And Accelerating 10.87
WillR(14)
Overbought -17.86
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
